Wednesday, February 26, 2014

FDA Advisory Panel Debates Ethics of "3-Parent Embryo" Procedure

USA Today: FDA raises concerns about three-parent embryo procedure, by Karen Weintraub:

In two days of hearings ending Wednesday, a federal committee proved quite skeptical about research that might help some patients birth healthy children — but might also open the door to human gene manipulation.

The procedure being considered, called mitochondrial transfer, would mix the genes of two women in hopes of creating a healthy baby. . . .

WebMD: FDA Explores '3-Person' Embryo Fertilization, by Dennis Thompson:

U.S. Food and Drug Administration hearings opened Tuesday on a controversial fertilization technique that uses the DNA from three people -- two women and one man -- with the goal of preventing inherited genetic diseases. . . .

https://lawprofessors.typepad.com/reproductive_rights/2014/02/fda-advisory-panel-debates-ethics-of-3-parent-embryo-procedure.html

Assisted Reproduction, Bioethics | Permalink

TrackBack URL for this entry:

https://www.typepad.com/services/trackback/6a00d8341bfae553ef01a5117737a3970c

Listed below are links to weblogs that reference FDA Advisory Panel Debates Ethics of "3-Parent Embryo" Procedure:

Comments

Post a comment